Limited induction of tumor cross-reactive T cells without a measurable clinical benefit in early melanoma patients vaccinated with human leukocyte antigen class I-modified peptides

Paola Filipazzi, Lorenzo Pilla, Luigi Mariani, Roberto Patuzzo, Chiara Castelli, Chiara Camisaschi, Andrea Maurichi, Agata Cova, Gianluigi Rigamonti, Felicetta Giardino, Annabella Di Florio, Marco Asioli, Paola Frati, Gloria Sovena, Paola Squarcina, Michele Maio, Riccardo Danielli, Vanna Chiarion-Sileni, Antonello Villa, Claudia LombardoGabrina Tragni, Mario Santinami, Giorgio Parmiani, Licia Rivoltini

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Limited induction of tumor cross-reactive T cells without a measurable clinical benefit in early melanoma patients vaccinated with human leukocyte antigen class I-modified peptides'. Together they form a unique fingerprint.

Medicine & Life Sciences